Journal of Clinical Oncology

J Clin Oncol · ISSN (print) 0732-183X · ISSN (e) 1527-7755 · 20 papers in corpus
2025
doi:10.1200/jco.24.00176 ·PMID:39356978

PurposeIt is uncertain whether, and to what extent, hormonal contraceptives increase breast cancer (BC) risk for germline BRCA1 or BRCA2 mutation carriers.MethodsUsing pooled observational data from four prospective cohort studies, associat…

other 2024
doi:10.1200/JCO.24.00602 ·PMID:38748943
2022
doi:10.1200/jco.21.01460 ·PMID:34995129

PurposeTo investigate whether a panel of circulating protein biomarkers would improve risk assessment for lung cancer screening in combination with a risk model on the basis of participant characteristics.MethodsA blinded validation study w…

meta-analysis 2022
doi:10.1200/jco.21.01900 ·PMID:35867953

PURPOSE: Frequent aspirin use has been associated with reduced ovarian cancer risk, but no study has comprehensively assessed for effect modification. We leveraged harmonized, individual-level data from 17 studies to examine the association…

article 2020
doi:10.1200/jco.2020.38.15_suppl.e18025

e18025 Background: Young patients with early stages of gynecological cancers often go through surgical menopause which worsens the quality of life affecting social, sexual, psycho-emotional, cognitive spheres, and causes somatic diseases ra…

article 2016
doi:10.1200/jco.2016.66.8178 ·PMID:27325851

PURPOSE: An understanding of the etiologic heterogeneity of ovarian cancer is important for improving prevention, early detection, and therapeutic approaches. We evaluated 14 hormonal, reproductive, and lifestyle factors by histologic subty…

2016
doi:10.1200/jco.2015.61.2259 ·PMID:26729437

PurposeTo describe estradiol (E2), estrone (E1), and estrone sulfate (E1S) levels during the first year of monthly triptorelin plus exemestane or tamoxifen and to assess possible suboptimal suppression while receiving exemestane plus tripto…

2015
doi:10.1200/jco.2015.61.6490 ·PMID:26527781

PurposeProgesterone receptors are expressed in approximately 70% of meningiomas. Mifepristone is an oral antiprogestational agent reported to have modest activity in a phase II study. This multicenter, prospective, randomized, placebo-contr…

2015
doi:10.1200/jco.2015.61.3083 ·PMID:26552420

PurposeType II ovarian cancer (OC) and endometrial cancer (EC) are generally diagnosed at an advanced stage, translating into a poor survival rate. There is increasing evidence that Müllerian duct cancers may exfoliate cells. We have establ…

other 2015
doi:10.1200/JCO.2014.58.3401 ·PMID:25624430

PURPOSE: The phosphoinositol-3 kinase (PI3K) pathway is frequently dysregulated in endometrial cancer (EC). Hormonal manipulation leads to response in some patients with EC, but resistance derived from PI3K pathway activation has been docum…

2015
doi:10.1200/jco.2014.59.4945 ·PMID:25964255

PurposeCancer screening strategies have commonly adopted single-biomarker thresholds to identify abnormality. We investigated the impact of serial biomarker change interpreted through a risk algorithm on cancer detection rates.Patients and …

2014
doi:10.1200/jco.2013.54.1987 ·PMID:25199754

PurposeRisk-reducing salpingo-oophorectomy (RRSO) lowers mortality from ovarian/tubal and breast cancers among BRCA1/2 mutation carriers. Uncertainties persist regarding potential benefits of RRSO among high-risk noncarriers, optimal surgic…

2014
doi:10.1200/jco.2014.55.6993 ·PMID:25349302

PurposeThe effects of ovarian function suppression (OFS) on survival and patient-reported outcomes were evaluated in a phase III trial in which premenopausal women were randomly assigned to tamoxifen with or without OFS.Patients and methods…

article 2013
doi:10.1200/jco.2012.44.1600 ·PMID:23460712
2013
doi:10.1200/jco.2011.39.7638 ·PMID:23213100

PurposeTo establish the performance characteristics of annual transvaginal ultrasound and serum CA125 screening for women at high risk of ovarian/fallopian tube cancer (OC/FTC) and to investigate the impact of delayed screening interval and…

article 2012
doi:10.1200/jco.2012.43.4274 ·PMID:23213089
2009
doi:10.1200/jco.2008.20.5179 ·PMID:19470930

PURPOSE To update the 2002 American Society of Clinical Oncology guideline on pharmacologic interventions for breast cancer (BC) risk reduction. METHODS A literature search identified relevant randomized trials published since 2002. Primary…

2008
doi:10.1200/jco.2008.16.4814 ·PMID:18757330

PurposeA diagnosis of primary peritoneal serous carcinoma (PPSC) requires exclusion of a source in other reproductive organs. Serous tubal intraepithelial carcinoma (STIC; stage 0) has been described in asymptomatic women with BRCA mutation…

article 2005
doi:10.1200/jco.2005.23.16_suppl.5050

5050 Background: Epithelial ovarian cancer (EOC) can be subdivided into five major histologic types (Serous(SC), Mucinous(MC), Endometrioid(EC), Clear cell(CC), Undifferentiated (UC)). Among them, CC generally has a poor response to combina…

other 1991
doi:10.1200/JCO.1991.9.6.983 ·PMID:1851822

Sialyl Tn antigen (NeuAc alpha 2----6GalNac alpha 1----0-Ser/Thr [STN]) with antigenic specificity in the core structure of mucin-type carbohydrate chains has been determined. In the present study, we evaluated the clinical significance of …